Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet Sells 2,401 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 2,401 shares of the firm’s stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the completion of the sale, the executive vice president now directly owns 353 shares in the company, valued at approximately $205,093. This trade represents a 87.18 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Myriam Curet also recently made the following trade(s):

• On Tuesday, February 11th, Myriam Curet sold 408 shares of Intuitive Surgical stock. The shares were sold at an average price of $589.75, for a total value of $240,618.00.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $563.77 on Friday. The firm has a market cap of $200.80 billion, a P/E ratio of 87.95, a P/E/G ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a 50-day simple moving average of $568.89 and a two-hundred day simple moving average of $527.90.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently made changes to their positions in ISRG. Atala Financial Inc purchased a new stake in Intuitive Surgical during the 4th quarter valued at $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at $26,000. Parvin Asset Management LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical in the 4th quarter worth about $28,000. Finally, Hurley Capital LLC purchased a new position in Intuitive Surgical in the 4th quarter worth about $28,000. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on ISRG. Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Citigroup lifted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Raymond James increased their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. BTIG Research lifted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Finally, Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.